$1.46
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Codexis to Participate in Cantor Global Healthcare Conference 2026
Codexis (CDXS) Q2 2026 Earnings Call Transcript
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
Overview
52-week range
$0.96
$2.98
25% of range
Avg surprise (last 3)
-3.3%
Avg reaction (last 2)
-3.3%
0% positive
Latest IV / EM
345%
EM ±57.6% · $2 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.13 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.10 | $-0.11 | +9.1% | +60.0% | -3.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.22 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.16 | $-0.17 | +5.9% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.25 | $-0.20 | -25.0% | — | -3.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.29 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.32 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.16 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.50 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.17 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.34 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $15M | — | $9M | $15M | $8M | — | $13M |
| Cost of revenue | $4M | $2M | — | $2M | $2M | $3M | — | $4M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-11M | $-8M | — | $-19M | $-13M | $-20M | — | $-17M |
| Net income | $-12M | $-9M | — | $-20M | $-13M | $-21M | — | $-21M |
| EPS (diluted) | $-0.13 | $-0.10 | — | $-0.22 | $-0.16 | $-0.25 | — | $-0.29 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27M | $37M | $51M | $25M | $27M | $18M | $19M | $37M |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M |
| Total current assets | $72M | $80M | $97M | $76M | $89M | $78M | $99M | $113M |
| Total assets | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M |
| Long-term debt | $34M | $40M | $40M | $40M | $39M | $29M | $29M | $29M |
| Total liabilities | $87M | $86M | $97M | $85M | $83M | $79M | $82M | $75M |
| Total equity | $33M | $43M | $51M | $39M | $56M | $50M | $67M | $73M |